Table 4.
ADRs (8 months) October 2011–June 2012 | Glyburide/Glibenclamide | Glimepiride | Tolbutamide | Repaglinide | Nateglinide | All drugs |
---|---|---|---|---|---|---|
Muscle atrophy (N) | 4 c (PRR = 12) (Chi Q = 0.3.) | 0 | 0 | 0 | 0 | 373 |
Total (N) | 1460 | 945 | 34 | 337 | 83 | 1,697,582 |
ADR, adverse drug reactions; PRR, proportional reporting ratio; c, indicates concomitant drug treatment.